BACOU USA INC
8-K, 1999-03-01
OPHTHALMIC GOODS
Previous: HENNESSY FUNDS INC, NSAR-A, 1999-03-01
Next: BACOU USA INC, 8-K, 1999-03-01











                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): February 24, 1999
 ------------------------------------------------------------------------------

                                 BACOU USA, INC.
                            -------------------------

             (Exact name of registrant as specified in its charter)

                                    DELAWARE
                                -----------------

                 (State or other jurisdiction of incorporation)

  0-28040                                                           05-0470688
  -----------------------------------------------------------------------------
 (Commission file number)                  (IRS Employer Identification Number)

                   10 Thurber Boulevard, Smithfield, RI 02917
         --------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

        Registrant's telephone number, including area code: 401-233-0333
                                                            -------------



<PAGE>


Item 5.  OTHER EVENTS

(a)      Pursuant  to  Form  8-K,  General   Instruction  F,  Registrant  hereby
         incorporates by reference the press release  attached hereto as Exhibit
         99.

(b)      Exhibits

         Item 601
         Exhibit                            Exhibit Title
         -----------                        ---------------

         Exhibit 99                         Press Release



<PAGE>


     SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                           BACOU USA, INC.
                                           Registrant



                                           By:  /s/Philip B. Barr
                                                ______________________________
                                                   Philip B. Barr
                                                   Executive Vice President and
                                                   Chief Financial Officer

Dated: February 26, 1999









Contact:
At the Company:                       At The Financial Relations Board
401-233-0333                          212-661-8030
Philip B. Barr                        Analyst Information       John McNamara
Chief Financial Officer               Media Information:        Alan Goldsand
Investor Relations                    General Information:      Jeff Bogart

FOR IMMEDIATE RELEASE

                        BACOU USA ELECTS NEW BOARD MEMBER

Smithfield,  R.I.,  February 25, 1999 -- Bacou USA, Inc. (NYSE:  BAU), a leading
manufacturer of personal  protective  equipment,  today announced that Alfred J.
Verrecchia has joined the Bacou USA Board of Directors,  which has been expanded
to eight  members.  Mr.  Verrecchia  is Executive  Vice  President and President
Global  Operations of Hasbro,  Inc. of Pawtucket,  Rhode Island,  a $3.3 billion
manufacturer of toys and games. Mr.  Verrecchia is also a member of the Board of
Directors of Hasbro, Inc.

     "We are very  pleased  that Al  Verrecchia  has agreed to join our Board of
Directors," said Walter Stepan,  Vice-Chairman,  President and CEO of Bacou USA.
"His extensive  experience in operations will be a valuable resource to us as we
continue  our  strategy of internal  growth and growth by  acquisition  at Bacou
USA." Mr. Verrecchia also will join the Compensation and Oversight Committees of
the Board at Bacou USA.

     Mr. Verrecchia,  age 56, also is a former President and currently serves as
a board member of the Rhode  Island  Public  Expenditure  Council and as a board
member and former Chair of Emma Pendleton Bradley Hospital. He is a board member
of Old Stone Corporation,  the United Way of Southeastern New England,  Lifespan
(a Rhode Island based healthcare  organization),  and Allendale Mutual Insurance
Company.  He recently  completed a  three-year  term as a member of the Board of
Governors for Higher Education in Rhode Island.  Mr. Verrecchia is a graduate of
the  University  of Rhode  Island,  holding  a  Bachelor  of  Science  degree in
Accounting and a Masters of Business Administration in Finance, and has received
an Honorary Doctor of Business  Administration  from Johnson & Wales University.
Mr. Verrecchia is a resident of Warwick, Rhode Island.

     Bacou USA, Inc. designs,  manufactures and sells leading brands of products
that protect the sight,  hearing and respiratory  systems of workers, as well as
related  instrumentation  including  visions  screeners,  gas  monitors and test
equipment  for  self-contained  breathing  apparatus.  The  company's  products,
marketed under Uvex(R), Howard Leight(R), Survivair(R), Pro-Tech(R), Biosystems,
Titmus(R),  LaserVision and Lase-R Shield brand names,  are sold  principally to
industrial safety distributors, fire fighting equipment distributors and optical
laboratories.  News  and  information  about  Bacou  USA  are  available  on the
Worldwide Web at http://www.bacouusa.com.

              To receive additional information on Bacou USA, Inc.,
                          via fax, at no charge, dial
                       1-800-PRO-INFO and enter code BAU.

                                       ###

Statements  contained in this press  release that are not  historical  facts are
forward-looking  statements that are made pursuant to the safe harbor provisions
of the Private Securities and Litigation Reform Act of 1995. In addition,  words
such  as  "believes,"  "anticipates,"  "expects"  and  similar  expressions  are
intended  to identify  forward-looking  statements.  Forward-looking  statements
involve  risks  and  uncertainties,  including  but not  limited  to the  timely
development and acceptance of new products,  the impact of competitive  products
and  pricing,   changing  market  conditions,   the  successful  integration  of
acquisitions, continued availability and favorable pricing of raw materials, the
ability of the company and its key vendors to successfully  respond to Year 2000
issues and the other risks detailed in the company's  prospectus filed March 27,
1996,  and  from  time to time in  other  filings.  Actual  results  may  differ
materially from those projected.  These forward-looking statements represent the
company's  judgment  as of the  date of this  release.  The  company  disclaims,
however, any intent or obligation to update these forward-looking statements.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission